Osteoclasts and effects of interleukin 4 in development of chronic osteomyelitis

Clinical Orthopaedics and Related Research

Volumn 355, Issue , 1998, Pages 290-299

  Pesanti, Edward L ^a   Lorenzo, Joseph A ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC OSTEOMYELITIS; CONTROLLED STUDY; MOUSE; NEUTROPHIL; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TIBIA;

EID: 0031733829     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199810000-00031     Document Type: Article

References (32)

1. Anthony JP, Mathes SJ, Alpert BS: The muscle flap in the treatment of chronic lower extremity osteomyelitis: Results in patients over 5 years after treatment. Plast Reconstr Surg 88:311-318, 1991.
2. Bartels KE: Nonunion. (Review). Vet Clin North Am - Small Anim Prac 17:799-809, 1987.
3. Bohm E, Josten C: What's new in exogenous osteomyelitis? Pathol Res Pract 188:254-258, 1992.
4. Clawson DK, Stevenson JK: Treatment of chronic osteomyelitis. Surg Gynecol Obstet 120:59-69, 1965.
5. Cole AA, Walters LM: Tartrate-resistant acid phosphatase in bone and cartilage following decalcification and cold-embedding in plastic. J Histochem Cytochem 35:203-206, 1987.
6. Cunningham R, Cockayne A, Humphreys H: Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections. J Med Microbiol 44:157-164, 1996.
7. Dirschl DR, Almekinders LC: Osteomyelitis. Common causes and treatment recommendations. Drugs 45:29-43, 1993.
8. Duncan GJ, Meals R: One hundred years of automobile-induced orthopedic injuries. Orthopedics 18:165-170, 1995.
9. Eckardt JJ, Wirganowicz PZ, Mar T: An aggressive surgical approach to the management of chronic osteomyelitis. Clin Orthop 298:229-239, 1994.
10. Evans RP, Nelson CL: Gentamicin-impregnated polymethylmethacrylate beads compared with systemic antibiotic therapy in the treatment of chronic osteomyelitis. Clin Orthop 295:37-42, 1993.
11. Evans RP, Nelson CL, Harrison BH: The effect of wound environment on the incidence of acute osteomyelitis. Clin Orthop 286: 289-297, 1993.
12. Fitzgerald Jr RH, Ruttle PE, Arnold PG, Kelly PJ, Irons GB: Local muscle flaps in the treatment of chronic osteomyelitis. J Bone Joint Surg 67A: 175-185, 1985.
13. Gallie WE: First recurrence of osteomyelitis eighty years after infection. J Bone Joint Surg 33B: 110-111, 1951.
14. Horowitz M, Lorenzo J: Local Regulators of Bone. IL-1, TNF, and Lymphotoxin, Interferon-Gamma, IL-8, IL-10, IL-4, the LIF/IL-6 Family, and Additional Cytokines. In Bilezikian JP, Raisz L, Rodan G (eds). Principals of Bone Biology. San Francisco, Academic Press 687-700, 1996.
15. Humason GL: Animal Tissue Techniques. Ed 4. San Francisco, JH Freeman and Co 1979.
16. Kahn DS, Pritzker KPH: The pathophysiology of bone infection. Clin Orthop 96: 12-19, 1973.
17. Lacey DL, Erdmann, JM, Teitelbaum SL, et al: Interleukin 4, interferon-gamma, and prostaglandin E impact the osteolastic cell-forming potential of murine bone marrow macrophages. Endocrinology 136: 2367-2376, 1995.
18. Marks SC, Grolman M: Tartrate-resistant acid phosphatase in mononuclear and multinuclear cells during the bone resorption of tooth eruption. J Histochem Cytochem 35: 1227-1230, 1987.
19. Norden CW: Diagnosis and treatment of osteomyelitis. Cutis 36: 13-14, 1985.
20. Norden CW: Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin. J Infect Dis 132: 493-499, 1975.
21. Norden CW, Myerowitz RL, Keleti E: Experimental osteomyelitis due to Staphylococcus aureus or Pseudomonas aeruginosa: A radiographic-pathological correlative analysis. Br J Exp Pathol 61: 451-460, 1980.
22. Rissing BJ: Animal models of osteomyelitis. Infect Dis Clin North Am 4: 377-390, 1990.
23. Rissing JP, Buxton TB, Weinstein RS, Shockley RK: Model of experimental chronic osteomyelitis in rats. Infect Immun 47: 581-586, 1985.
24. Sanderson C, Radley K, Mayton L: Ethylenediaminetetraacetic acid in ammonium hydroxide for reducing decalcification time. Biotech Histochem 70:12-18, 1995.
25. Scheman L, Janota M, Lewin P: The production of experimental osteomyelitis. JAMA 117:1525-1529, 1941.
26. Suda T, Takahashi N, Martin TJ: Modulation of osteoclast differentiation. Endocr Rev 13:66-80, 1992.
27. Thompson RHS, Dubos RJ: Production of experimental osteomyelitis in rabbits by intravenous injection of Staphylococcus aureus. J Exp Med 68:191-206, 1938.
28. Trueta J, Morgan JD: Late results in the treatment of one hundred cases of acute hematogenous osteomyelitis. Br J Surg 41:449-457, 1954.
29. Vargas SJ, Naprta A, Glaccum M, et al: Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor. J Bone Miner Res 11:1736-1744, 1996.
30. Wald ER: Risk factors for osteomyelitis. Am J Med 78:206-12, 1985.
31. Waldvogel FA, Medoff G, Swartz MN: Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects. (Parts I, II, and III). N Engl J Med 282:198-206, 260-266, 316-322, 1970.
32. Yamamoto M: An experimental study on Pseudomonas osteomyelitis with special reference to the production of experimental osteomyelitis in mice. Nippon Seikeigeka Gakkai Zasshi 53:777-792, 1979.